Overview
- 53 inspections across 50 sites are on record.
- 32 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-01.
At a glance
Inspections
53
Sites
50
Observations
32
Career since
Jan 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| SCL Lifesciences Limited | 1 May 2026 | Human Drugs | On file |
| Wockhardt Limited | 24 Apr 2026 | Human Drugs | |
| Ajanta Pharma Ltd. | 21 Apr 2026 | Human Drugs | On file |
| Aurobindo Pharma Limited | 10 Feb 2026 | Human Drugs | On file |
| Centrient Pharmaceuticals India Private Limited | 27 Jan 2026 | Human Drugs | On file |
Sites inspected
SCL Lifesciences LimitedDerabassi, India1 insp.
Wockhardt LimitedAurangabad, India1 insp.
Ajanta Pharma Ltd.Paithan, India1 insp.
Aurobindo Pharma LimitedJedcherla Mandal, Mahabubnagar, India1 insp.
Centrient Pharmaceuticals India Private LimitedNawashahr, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Tamil Arasu3 shared
Pratik S Upadhyay2 shared
Elizabeth R Bloom2 shared
Ramia Brzenjy2 shared
Tyler M Peterson2 shared
Anastasia M Shields2 shared
Lori B Wikstrom2 shared
Vaishali J Patel2 shared
Brian D Nicholson2 shared
Norman K Starks2 shared
Full investigator report
Get the verbatim findings behind Nibin Varghese's 32 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site